## Abstract ## Background and Objectives Curative hepatic resection (CHR) was a modality that provides possibility of longβterm survival for hepatocellular carcinoma (HCC). So far, prognostic factors of male patients with HCC after CHR remain unclear. Purposes of the present study were to identify
β¦ LIBER β¦
Long-term survival of a patient with advanced adenosquamous carcinoma of the gallbladder after radical resection
β Scribed by Fujita, Takeo ;Fukuda, Kazuma ;Ohmura, Yasushi ;Nishi, Hideyuki ;Mano, Masayuki ;Komatsubara, Syokichi ;Doihara, Hiroyoshi ;Shimizu, Nobuyoshi
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 312 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0944-1166
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Factors predictive for long-term surviva
β
Li Zhou; Jing-An Rui; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu; Tian-Yi Chi; Xue
π
Article
π
2007
π
John Wiley and Sons
π
English
β 182 KB
π 1 views
A long-term surviving patient with cance
β
Hamada, Nobuo ;Tanaka, Koki ;Ishizaki, Naoki ;Komokata, Teruo ;Nakamura, Noboru
π
Article
π
1998
π
Springer
π
English
β 402 KB
Long-term survival in Japanese patients
β
Daisuke Korenaga; Shunichi Tsujitani; Masaru Haraguchi; Takeshi Okamura; Ryuichi
π
Article
π
1988
π
Springer
π
English
β 427 KB
Long-term survival in a patient with hep
β
Shinji Togo; Tetsuya Takahashi; Kuniya Tanaka; Itaru Endo; Hitoshi Sekido; Hiros
π
Article
π
2004
π
Springer
π
English
β 433 KB
Long-term Survival of Patients with Gall
β
Tomotaka Akatsu; Masakazu Ueda; Motohide Shimazu; Go Wakabayashi; Koichi Aiura;
π
Article
π
2005
π
Springer
π
English
β 131 KB
Long-term survival of resectable subset
β
Yo-Han Cho; Se Hoon Lee; Dong-Wan Kim; Hong-Gyun Wu; J. Hun Hah; Chae-Seo Rhee;
π
Article
π
2008
π
John Wiley and Sons
π
English
β 169 KB
π 1 views
## Abstract ## Background. Although metaβanalysis showed that survival improved with concurrent chemoradiation in locally advanced head and neck cancer, neoadjuvant chemotherapy is still unique, because it renders curative surgery feasible for marginally resectable head and neck cancer patients.